Table 3.
The presentation of the capture of CTCs by the straight and spiraled CellCollector.
| Straight Wire—Ex Vivo | Spiraled Wire—Ex Vivo | |||
|---|---|---|---|---|
| Captured CTCs as Median (Range) | CTC Positive (%) | Captured CTCs as Median (Range) |
CTC Positive (%) | |
| Metastatic | ||||
| pT1 | 9 (7–44) | 100 | ||
| pT2 | 5 (2–24) | 100 | ||
| pT3 | 5.5 (2–9) | 100 | 5 (2–11) | 100 |
| n.a. | 0 | 0 | ||
| all | 5.5 (2–9) | 100 | 6 (0–44) | 98.82 |
| ccRCC | 2.5 (2–3) | 100 | 7 (0–24) | 84.62 |
| p/cRCC | 8.5 (8–9) | 100 | ||
| cRCC | 12 | 100 | ||
| n.a. | 3.5 (2–44) | 100 | ||
| Local | ||||
| pT1 | 5.5 (0–11) | 50 | 2 (0–5) | 50 |
| Control | ||||
| 0 (0–1) | 33.33 | 0.5 (0–1) | 50 | |
| Straight Wire—In Vivo | ||||
| Captured CTCs (range) | CTC positive (%) | |||
| Metastatic | ||||
| pT1 | 2 a | 100 | ||
| pT2 | 7 (10–4) b | 100 | ||
| Local | ||||
| pT2 | 2 a | 100 | ||
| pT3 | 5 (10–0) b | 50 | ||
ccRCC—clear cell renal cell carcinoma, pRCC—papillary renal cell carcinoma, cRCC—chromophilic renal cell carcinoma, p/cRCC—papilary/chromofilic renal cell carcinoma, p.d. RCC—poorly differentiated renal cell carcinoma, n.a.—not available. a Single wire, b data obtained from one patient displayed as the median (therapy monitoring).